{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:59:45Z","timestamp":1782863985137,"version":"3.54.5"},"reference-count":75,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T00:00:00Z","timestamp":1695945600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["HIV Medicine"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>Review the evidence on the incidence and impact of herpes zoster among people living with HIV and the potential impact of recombinant zoster vaccine for people aging with HIV.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Narrative review.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Although antiretroviral therapy has substantially reduced the risk of herpes zoster among people living with HIV, they remain at an increased risk compared with the general population. Among people aging with HIV, aging per se is now the main risk factor for herpes zoster. Beyond pain, herpes zoster is also associated with a risk of sight\u2010threatening complications in case of trigeminal involvement, disseminated diseases and stroke. Post\u2010herpetic neuralgia is also a potential threat to the quality of life of people aging with HIV. The recombinant zoster vaccine has demonstrated high and sustained efficacy in the prevention of herpes zoster, post\u2010herpetic neuralgia, and other herpes zoster complications in the general population. Immunogenicity data among people living with HIV with high CD4+ T\u2010cell count and controlled viral load are comparable to those among the general population. Real\u2010life effectiveness data indicate high vaccine efficacy among immunocompromised patients other than people living with HIV. High vaccine price, vaccine hesitancy, and limited disease and vaccine awareness represent potential hurdles for high vaccine uptake among people aging with HIV in Europe.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Herpes zoster, and its complications, is a vaccine\u2010preventable disease of aging people. Given its impact on quality of life, herpes zoster prevention using recombinant zoster vaccine is a safe strategy to be considered in every person aging with HIV.<\/jats:p><\/jats:sec>","DOI":"10.1111\/hiv.13548","type":"journal-article","created":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T11:33:09Z","timestamp":1695987189000},"page":"1190-1197","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The value of herpes zoster prevention in people aging with <scp>HIV<\/scp>: A narrative review"],"prefix":"10.1111","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7697-6849","authenticated-orcid":false,"given":"Nicolas","family":"Dauby","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases CHU Saint\u2010Pierre, Universit\u00e9 Libre de Bruxelles (ULB)  Brussels Belgium"},{"name":"School of Public Health Universit\u00e9 Libre de Bruxelles (ULB)  Brussels Belgium"},{"name":"U\u2010CRI, Universit\u00e9 Libre de Bruxelles (ULB)  Brussels Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7677-3323","authenticated-orcid":false,"given":"Christian","family":"Motet","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases CHU Saint\u2010Pierre, Universit\u00e9 Libre de Bruxelles (ULB)  Brussels Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6078-878X","authenticated-orcid":false,"given":"Agn\u00e8s","family":"Libois","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases CHU Saint\u2010Pierre, Universit\u00e9 Libre de Bruxelles (ULB)  Brussels Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8995-6230","authenticated-orcid":false,"given":"Charlotte","family":"Martin","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases CHU Saint\u2010Pierre, Universit\u00e9 Libre de Bruxelles (ULB)  Brussels Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,9,29]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiab387"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.16"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz1090"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz769"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202048922"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.091711"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-1059-9"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.3325\/cmj.2020.61.401"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2278-z"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13365-023-01144-0"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198112103052402"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(86)70127-8"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/157.2.314"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365548809032451"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/166.5.1153"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1086\/528696"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1086\/605611"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit165"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy1041"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2013.06.016"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu1161"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-004833"},{"key":"e_1_2_12_24_1","unstructured":"International Coalition of Older People with HIV (iCOPe HIV). The Glasgow Manifesto.2022https:\/\/www.eatg.org\/press\u2010releases\u2010and\u2010statements\/the\u2010glasgow\u2010manifesto\u2010by\u2010the\u2010international\u2010coalition\u2010of\u2010older\u2010people\u2010with\u2010hiv\u2010icope\u2010hiv\/"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2016.04.013"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1080\/09540121.2012.748881"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2010.04.004"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2023.03.058"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1497.2005.0150.x"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e318266cd3c"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.7448\/IAS.17.1.18719"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002021"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2014.0104"},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000000462"},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002808"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10389-011-0481-8"},{"key":"e_1_2_12_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-016-0548-x"},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25449"},{"key":"e_1_2_12_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw047"},{"key":"e_1_2_12_40_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu918"},{"key":"e_1_2_12_41_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2018.1495565"},{"key":"e_1_2_12_42_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1501184"},{"key":"e_1_2_12_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy095"},{"key":"e_1_2_12_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.02.029"},{"key":"e_1_2_12_45_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab629"},{"key":"e_1_2_12_46_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiab580"},{"key":"e_1_2_12_47_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1442162"},{"key":"e_1_2_12_48_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab121"},{"key":"e_1_2_12_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2021.04.017"},{"key":"e_1_2_12_50_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu606"},{"key":"e_1_2_12_51_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.9053"},{"key":"e_1_2_12_52_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab125"},{"key":"e_1_2_12_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.07.005"},{"issue":"1","key":"e_1_2_12_54_1","first-page":"1","article-title":"Cost\u2010effectiveness of vaccination of immunocompetent older adults against herpes zoster in The Netherlands: a comparison between the adjuvanted subunit and live\u2010attenuated vaccines","volume":"16","author":"Boer PT","year":"2018","journal-title":"BMC Med"},{"key":"e_1_2_12_55_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.190274"},{"key":"e_1_2_12_56_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2021.2002085"},{"key":"e_1_2_12_57_1","article-title":"Vaccines for preventing herpes zoster in older adults","volume":"3","author":"Gagliardi AM","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_12_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.11.058"},{"key":"e_1_2_12_59_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2021.1956906"},{"key":"e_1_2_12_60_1","unstructured":"Conseil Sup\u00e9rieur de la Sant\u00e9. Vaccination contre l'herp\u00e8s zoster CSS n\u00b09684.Service public f\u00e9d\u00e9ral (SPF) Sant\u00e9 publique S\u00e9curit\u00e9 de la Cha\u00eene alimentaire et Environnement.2022.https:\/\/www.health.belgium.be\/sites\/default\/files\/uploads\/fields\/fpshealth_theme_file\/20220906_css\u20109684_herpes_zoster_vweb.pdf"},{"key":"e_1_2_12_61_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1391"},{"key":"e_1_2_12_62_1","unstructured":"European AIDS Clinical Society.EACS Guidelines Version 11.1.2022.https:\/\/www.eacsociety.org\/media\/guidelines-11.1_final_09-10.pdf"},{"key":"e_1_2_12_63_1","first-page":"1","article-title":"Seroprevalence of varicella\u2010zoster virus and predictors for seronegativity in the Amsterdam adult population","volume":"12","author":"Rijckevorsel GG","year":"2012","journal-title":"BMC Infect Dis"},{"key":"e_1_2_12_64_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1534517"},{"key":"e_1_2_12_65_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1509644"},{"key":"e_1_2_12_66_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18094901"},{"key":"e_1_2_12_67_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9040302"},{"key":"e_1_2_12_68_1","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12483"},{"key":"e_1_2_12_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.07.004"},{"key":"e_1_2_12_70_1","article-title":"Herpes zoster following recombinant zoster vaccine with or without concomitant vaccination. Open forum","volume":"9","author":"Bruxvoort KJ","year":"2022","journal-title":"Infect Dis"},{"key":"e_1_2_12_71_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2204785"},{"key":"e_1_2_12_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.10.076"},{"key":"e_1_2_12_73_1","doi-asserted-by":"crossref","unstructured":"TatonM WillemsF WidomskiC et al.HIV\u2010related immune activation compromises polyfunctional IgG and memory B\u2010Cell responses to Tdap immunization during pregnancy.2023. Preprint. Available at SSRN:https:\/\/ssrn.com\/abstract=4420762","DOI":"10.2139\/ssrn.4420762"},{"key":"e_1_2_12_74_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079816"},{"key":"e_1_2_12_75_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu840"},{"key":"e_1_2_12_76_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa300"}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hiv.13548","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T02:31:15Z","timestamp":1703557875000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hiv.13548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,29]]},"references-count":75,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.1111\/hiv.13548"],"URL":"https:\/\/doi.org\/10.1111\/hiv.13548","archive":["Portico"],"relation":{},"ISSN":["1464-2662","1468-1293"],"issn-type":[{"value":"1464-2662","type":"print"},{"value":"1468-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,29]]},"assertion":[{"value":"2023-06-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-11","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}